Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001641172-25-013339

Chief Financial Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Weiler Peter J. Chief Financial Officer 2025-05-29 Grant or award +65,000 65,000 D
Loading xslF345X05/ownership.xml…